An increase in the ADGRL2 levels improves endothelial functionality, and this aGPCR could therefore be a promising therapeutic target for the treatment of sepsis to protect the endothelium and, thus, to restore endothelial cell integrity. The gene discussed is ADGRL2; the disease is Sepsis.